Clinical Trial

Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The investigators hypothesize that single oral high dose supplementation with vitamin A will reduce the incidence of moderate-severe chronic graft-versus-host disease (GVHD) compared with placebo.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2024-06-05; most recent amendment 2025-08-11.
Status change: Not Yet Recruiting → Recruiting 2025-08-11
Trial Details
NCT Number NCT06450925
Lead Sponsor Children's Hospital Medical Center, Cincinnati
Conditions Graft Vs Host Disease, Vitamin A Deficiency, Vitamin D Deficiency
Enrollment 190 participants
Start Date 2025-03-25
Primary Completion 2027-08 (estimated)
Study Completion 2029-08 (estimated)
Updated on ClinicalTrials.gov 2025-08-12